the aid library

LIST OPTIONS

Filter

6836

Air Pollution - WHO

World Health Organisation (WHO) (2022) C_WHO

Accessed on 06.03.2022 Air pollution is contamination of the indoor or outdoor environment by any chemical, physical or biological agent that modifies the natural characteristics of the atmosphere. Household combustion devices, motor vehicles, industrial facilities and forest fires are common sou... more

Download (121)

View PDF (186)

Air pollution and child health: prescribing clean air: summary

World Health Organisation (WHO) (2018) C_WHO

This report summarizes the latest scientific knowledge on the links between exposure to air pollution and adverse health effects in children. It is intended to inform and motivate individual and collective action by health care professionals to prevent damage to children’s health from exposure to ... more

Download (134)

View PDF (170)

Pollution de l'air et santé de l'enfant : prescrire un air sain : résumé

World Health Organisation (WHO) (2018) C_WHO

Download (99)

View PDF (164)

Contaminación atmosférica y salud infantil: prescribir aire limpio: resumen

World Health Organisation (WHO) (2018) C_WHO

25 Years of Children and Armed Conflict: Taking Action to Protect Children in War. Fact Sheet

UN Children's Fund UNICEF (2022) C_UNICEF

The report also provides country-specific examples showing how direct engagement translated into the adoption of concrete measures, including national legislation and policies. Finally, the report presents key recommendations aimed at intensifying the actions of the international and the humanitaria... more

Economically disadvantaged countries are under threat of failing to accomplish SDG 3 by 2030

Rüppel, J.; Rüppel T. (2019) CC

It is of utmost importance to low-income countries and some lower-middle income nations in the time of the SDG period that they are not on course to accomplish the health-related SDG 3 and its targets until 2030. If we honestly intend to support this goal and realize it for the people living in the ... more

Download (162)

View PDF (235)

Urban HEART : Urban Health Equity Assessment and Response Tool

World Health Organization WHO (2010) C_WHO

The Urban Health Equity Assessment and Response Tool (Urban HEART) is a user-friendly guide for policy- and decision-makers at national and local levels to: identify and analyse inequities in health between people living in various parts of cities, or belonging to different socioeconomic groups with... more

Experience of living with type 1 diabetes in a low-income country: a qualitative study from Liberia

Adler, A.J.; Trujillo, C.; Schwartz, L.; et al. BMJ Journals (2021) CC

While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by challenges in diagnosis and management. These challeng... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (154)

View PDF (184)

Global HIV & AIDS statistics — World AIDS Day 2020 Fact Sheet
recommended

UNAIDS (2022) C_WHO

July 2022

Download (169)

View PDF (187)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 10 August 2023

World Health Organization WHO (2023) C_WHO

The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... more

Intention to action series: Regional reflections. Analysis from informal regional consultations with people living with noncommunicable diseases and mental health conditions 2023 WHO

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit... more

Download (83)

View PDF (134)

Fact Sheet– Global AIDS Update 2019

UNAIDS (2019) C2

2018 Global HIV Statistics

Download (152)

View PDF (208)

Region profiles — Global AIDS update 2019

UNAIDS (2019) C_WHO

Download (303)

View PDF (634)

UNAIDS: Global Plan Countryfact Sheet Uganda 2016

UNAIDS (2016) C1

Download (457)

View PDF (1279)

UNAIDS Global Plan Country Fact Sheet Uganda

UNAIDS (2016) C1

Download (308)

View PDF (506)

Living conditions among People with Disabilities in Swaziland: A national representative study

Arne H Eide & Bhekie Jele SINTEF Technology and Society (2011) C1

This is a report from a National, representative household survey carried out in Swaziland in 2009 – 2010. A large amount of effort has been put into this two‐year exercise until finally we can present the results of the combined efforts. First of all, this is a credit to the Federation of Disab... more

Download (106)

View PDF (158)

Global AIDS Monitoring 2021 — Regional indicators to measure progress towards zero discrimination — Additional guidance for Latin American and Caribbean countries

World Health Organization WHO (2020) C_WHO

All countries in the Latin American and Caribbean (LAC) region are expected to report on these indicators for the year 2020.

Global Land Outlook Second Edition: Land Restoration for Recovery and Resilience

UN Convention to Combat Desertification (2022) CC

27 April 2022 Chronic land degradation: UN offers stark warnings and practical remedies in Global Land Outlook 2. GLO2 offers hundreds of examples from around the world that demonstrate the potential of land restoration. The way land resources – soil, water and biodiversity – are currently mi... more

Download (172)

View PDF (203)

The Global Drug Policy Index 2021

Global Commission on Drug Policy (2021) CC

The power of the Global Drug Policy Index lies in its key objective: to score and rank how countries are faring in different areas of drug policy as identified in the UN report ‘What we have learned over the last ten years: A summary of knowledge acquired and produced by the UN system on drug-r... more

Global HIV & AIDS statistics — World AIDS Day 2020 Fact Sheet recommended

Global HIV & AIDS statistics — World AIDS Day 2020 Fact Sheet
recommended